Akero Therapeutics Inc (AKRO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $54.65

About Akero Therapeutics Inc

Akero Therapeutics, Inc. is a biotechnology firm based in South San Francisco, California, dedicated to pioneering innovative therapies for nonalcoholic steatohepatitis (NASH), a prevalent liver disease associated with cardiometabolic health issues. Utilizing its proprietary drug development platform, the company aims to restore metabolic balance and improve patient outcomes, positioning itself as a leader in addressing the unmet needs of individuals afflicted by metabolic disorders. Akero's ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Akero Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does AKRO pay dividends?

Akero Therapeutics Inc (AKRO) does not currently pay a regular dividend.